Insider plans Olema (NASDAQ: OLMA) sale after prior $2.9M trades

Rhea-AI Filing Summary

Olema Oncology insider plans additional stock sale under Rule 144. A holder has filed to sell 10,000 shares of Olema common stock through Fidelity Brokerage Services on NASDAQ, with an aggregate market value of $238,498.19, targeting an approximate sale date of 02/12/2026.

The 10,000 shares were acquired on 06/15/2020 via restricted stock vesting from the issuer as compensation. In the past three months, the same seller disposed of 3,822 common shares for gross proceeds of $107,069.20 and 100,000 common shares for gross proceeds of $2,873,214.99.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	10000	238498.19	68659923	02/12/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/15/2020	Restricted Stock Vesting	Issuer			10000	06/15/2020	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Shane W. Kovacs 780 Brannan Street San Francisco CA 94103	Common	01/13/2026	3822	107069.20
Shane W. Kovacs 780 Brannan Street San Francisco CA 94103	Common	01/15/2026	100000	2873214.99

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the latest Form 144 filing for OLMA disclose?

The filing shows an insider plans to sell 10,000 Olema common shares under Rule 144. The planned sale, through Fidelity on NASDAQ, reflects stock originally acquired via restricted stock vesting as compensation, and follows prior sales reported over the last three months.

How many Olema (OLMA) shares are planned for sale in this Form 144?

The notice covers a planned sale of 10,000 Olema common shares. These shares carry an aggregate market value of $238,498.19 in the filing and are scheduled for sale around 02/12/2026 through Fidelity Brokerage Services on the NASDAQ market.

How were the Olema (OLMA) shares in this Form 144 originally acquired?

The 10,000 Olema shares were acquired on 06/15/2020 via restricted stock vesting. The issuer granted the stock as compensation, and the filing specifies the acquisition date, nature of the transaction, and that the consideration was compensation rather than a cash purchase.

What Olema (OLMA) stock sales has the filer made in the last three months?

The filer sold 3,822 Olema common shares on 01/13/2026 for gross proceeds of $107,069.20. They also sold 100,000 common shares on 01/15/2026, generating gross proceeds of $2,873,214.99, as disclosed in the recent three‑month sales section.

Which broker and exchange are involved in the new Olema (OLMA) share sale?

The planned 10,000‑share sale will be executed through Fidelity Brokerage Services LLC. The filing lists Fidelity’s Smithfield, Rhode Island address and identifies NASDAQ as the securities exchange where the Olema common shares are expected to be sold.

What representation does the Olema (OLMA) Form 144 filer make about information?

By signing the notice, the seller represents they do not know any material adverse information about Olema’s current or prospective operations that has not been publicly disclosed. This representation also ties to any written trading plan adopted under Rule 10b5‑1.